- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $96.66M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $110.76M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $8.79M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $10.53M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $9.23M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $11.08M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $98.17M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $113M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $99.88M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $114.91M |
| Net Income | Q1 2025 · Dec 31, 2024 | −$17.44M |
| Net Income | Q1 2025 · Sep 30, 2024 | −$11.56M |
| Net Income | Q1 2025 · Jun 30, 2024 | −$14.14M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$9.54M |
| Stockholders Equity | Q1 2025 · Sep 30, 2024 | −$135.05M |
| Stockholders Equity | Q1 2025 · Jun 30, 2024 | −$123.58M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$111.26M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | −$101.84M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 314.02K sh |
| Capex | Q1 2025 · Mar 31, 2024 | $9K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$10.63M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$30.37 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$30.37 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $1.27M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $8.57M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$9.83M |